Pfizer Inc. recalls Buprenorphine Hydrochloride Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility-The potential for incomplete crimp seals.
- Products
-
- Buprenorphine Hydrochloride Injection
- Company
- Pfizer Inc.
- Where it was sold
-
US Nationwide and Puerto Rico.
Nationwide
- Units affected
- 84,710 cartridges
- About this recall
- Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03